Psychopharmakotherapie

Aims & Scope

„Psychopharmakotherapie“ (PPT) is the only German-language journal with a single focus on the pharmacotherapy of psychiatric and neurologic diseases, especially under the aspects pharmacology, evaluation in clinical studies, postmarketing surveillance, drug risks, pharmacoeconomics, and practical experiences .

Its aim is to inform German-speaking psychiatrists and neurologists (clinicians as well as practitioners) on best practice and current developments in this field.

PPT provides reviews, original (= research) papers, editorials, commentaries, case reports, and short reports on high-level publications and congress presentations.

Reviews, original papers, commentaries, and case reports are subject to peer review.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Behandlung von Antipsychotikainduzierter Gewichtszunahme

  Citation: 0

  Authors: Alkomiet

• Pharmakotherapie der Alkoholabhängigkeit

  Citation: 0

  Authors: Tilman, Mathias, Lars, Ulrich W., Friedrich M., Barbara

• Clozapin 2025 – zwischen Wirksamkeit und Komplikationen?

  Citation: 0

  Authors: Alkomiet, Elias

• Pharmakokinetik eines neuen biphasisch freisetzenden Methylphenidat-Präparats (Methysym^®)

  Citation: 0

  Authors: Sven, Britta, Helene, Ulrich

• Fahreignung unter Psychopharmaka – ein Update

  Citation: 0

  Authors: Gerd, Alexander

• Wie entstehen therapeutische Referenzbereiche für Psychopharmaka?

  Citation: 0

  Authors: Xenia, Christoph, Georgios

• Atogepant

  Citation: 0

  Authors: Hans-Christoph, Dagny

• Was bedeutet die EU-HTA-Verordnung für Zulassung und Nutzenbewertung von Neuropsychopharmaka?

  Citation: 0

  Authors: Karl, Marion, Antje, Georgios, Wiebke

• Wichtige Interaktionen in der Psychopharmakotherapie

  Citation: 0

  Authors: Martina, Patrick, Diana, Sibyllle C., Catharina

• Verordnung von Neuro-Psychopharmaka

  Citation: 0

  Authors: Jürgen, Stefan